The enigma of pseudohypoaldosteronism.
The syndrome of primary pseudohypoaldosteronism (PHA) is a hereditary disease characterized by increased aldosterone secretion associated with clinical signs of hypoaldosteronism. These include salt wasting and failure to thrive in the newborn, high urinary sodium, hyponatremia, hyperkalemia, and metabolic acidosis. Plasma renin activity is usually elevated in association with aldosterone. The clinical manifestation of the disease is variable, including severely affected patients who may die in infancy and patients who are asymptomatic. The disease seems to result from a cellular resistance to mineralocorticoid action, which could be either generalized, or restricted to the kidney. The condition is inherited as an autosomal dominant or an autosomal recessive trait; however, sporadic cases have been described. In this paper we report a 20-year follow-up study of a French family affected by PHA and we discuss the pathogenesis of the disease.
Zennaro
M C
MC
INSERM U36, Collège de France, Paris.
Borensztein
P
P
Soubrier
F
F
Armanini
D
D
Corvol
P
P
D000450:Aldosterone / Q000097:blood / Q000378:metabolism / Q000652:urine; D005260:Female; D005602:France; D006801:Humans; D007223:Infant; D008297:Male; D010375:Pedigree; D011546:Pseudohypoaldosteronism / Q000175:diagnosis / Q000235:genetics / Q000503:physiopathology*; D012083:Renin / Q000097:blood
D000450:Aldosterone; D012083:Renin